News
Our latest news, updates and press releases.
ViCentra and Bosman renew distribution agreement for Kaleido in the Netherlands
ViCentra is proud to share that its distribution agreement with Bosman Medical Supplies, part of OneMed, has recently been renewed. The renewal continues the exclusive agreement made in 2017 for the distribution of the Kaleido insulin pump across the Netherlands....
Kaleido wins at the AVA Digital Awards 2019!
ViCentra is very happy to share that the recently redesigned website for Kaleido, our insulin delivery system, has been named a Platinum winner in the “Web-Based Production: Medical” category at the AVA Digital Awards 2019. The AVA Digital Awards is an international...
ViCentra holds bloggers meeting at EASD conference in Berlin
The EASD (European Association for the Study of Diabetes) congress is a yearly get together of health care professionals, researchers, businesses and members of the diabetes online community. Research results are presented, there’s time to catch up with acquaintances...
Kaleido to fully launch for adults in the Netherlands
Following a successful pilot scheme at a small selection Dutch hospitals, Kaleido has now fully launched in the Netherlands. As the company behind the smallest and lightest insulin pump in the world, at ViCentra we’re proud to announce that our first Kaleidoers...
ViCentra’s insulin pump Kaleido fully reimbursed in the Netherlands
Kaleido, the smallest and lightest insulin pump in the world, is now available to be fully reimbursed by all health insurance companies in the Netherlands. As the company behind Kaleido, at ViCentra we’ve worked hard to secure agreements with every health insurance...
Kaleido wins at the Transform Awards Europe 2017!
ViCentra is delighted to announce that Kaleido – our hotly-anticipated new insulin delivery system – was awarded Bronze in the category ‘Best visual identity from the healthcare and pharmaceutical sector’ at last week’s eighth annual Transform Awards Europe....
ViCentra announces new Chairman of the Board
Leading late-stage startup ViCentra, a company focused on the development, manufacture and commercialisation of Kaleido, the insulin pump designed to help people with diabetes live life on their own terms, has today announced the appointment of Jan Keltjens to the...
ViCentra and Bosman sign distribution agreement for Kaleido in the Netherlands
Here at ViCentra, we’re delighted to announce that we have recently signed an agreement with Bosman Medical Supplies, part of OneMed, for distribution of the Kaleido insulin pump across the Netherlands. This exclusive deal with one of the Netherlands’ largest...
ViCentra appoints two new medical and scientific advisors
ViCentra, manufacturer of the Kaleido insulin delivery system, today announced the appointment of Dr. David Kerr and Dr. Fred Storms as medical and scientific advisors to its team. Drs. Kerr and Storms are both internationally recognised experts in the treatment of...